Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer. | Lancet;379(9833): 2237; author reply 2238, 2012 Jun 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer.

Brede-Hekimian, Katya.

Lancet ; 379(9833): 2237; author reply 2238, 2012 Jun 16.

Article in En | MEDLINE | ID: mdl-22704161

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/antagonists & inhibitors; Breast Neoplasms/chemistry; Breast Neoplasms/drug therapy; Receptor, ErbB-2/antagonists & inhibitors; Female; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Receptor, ErbB-2 Limits: Female / Humans Language: En Journal: Lancet Year: 2012 Document type: Article Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Receptor, ErbB-2 Limits: Female / Humans Language: En Journal: Lancet Year: 2012 Document type: Article Country of publication: United kingdom